(Q57826741)

English

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial

article

Statements

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit